Need for Long-Term Clinical Trials Most trials evaluating liraglutide, semaglutide, tirzepatide, and retatrutide in adolescents have lasted 5672 weeks, which may not be sufficient to assess long-term metabolic, cardiovascular, and developmental effects
The improved thermal stability and activity of LaccID at neutral pH could prove useful in these settings
Nurxs women-focused positioning is a meaningful differentiator
Since cellular performance adaptations arise from gene expression changes, the team screened for regulatory proteins that can flip on advantageous gene programs during prolonged GLP-1 use

Patients should contact their GP or prescribing clinician if they experience: Severe or persistent cramps that do not respond to simple measures or significantly impact daily activities and sleep quality Frequent cramping occurring multiple times daily or nightly Associated symptoms such as muscle weakness, numbness, tingling, or changes in sensation, which may indicate neurological involvement Visible muscle changes including swelling, redness, tenderness, or asymmetry between legs Signs of dehydration such as dizziness, reduced urine output, dark urine, or confusion These features may indicate underlying conditions requiring investigation, such as significant electrolyte disturbances, peripheral neuropathy (particularly relevant in diabetes), peripheral arterial disease, or, rarely, more serious muscle disorders